Waiting
Login processing...

Trial ends in Request Full Access Tell Your Colleague About Jove
Journal / Cancer Research / CRISPR/Cas9 kullanarak Gene sitokin bağımlı…
JoVE Journal
Cancer Research

A subscription to JoVE is required to view this content.

JoVE Journal Cancer Research
CRISPR/Cas9 kullanarak Gene sitokin bağımlı hematopoetik hücreler Mutant Calreticulin Oncogenic etkinliğini araştırmak için düzenleme
Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles
Journal (Cancer Research)
Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles
ATAC-Seq Optimization for Cancer Epigenetics Research
Journal (Cancer Research)
ATAC-Seq Optimization for Cancer Epigenetics Research
 
Click here for the English version

CRISPR/Cas9 kullanarak Gene sitokin bağımlı hematopoetik hücreler Mutant Calreticulin Oncogenic etkinliğini araştırmak için düzenleme

Article DOI: 10.3791/56726-v • 10:21 min • January 5th, 2018
January 5th, 2018 •
1, 1,2,3
1Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 2Broad Institute, 3Dana-Farber Cancer Institute, Harvard Medical School

Chapters

Summary
Automatic Translation

Please note that all translations are automatically generated.

Click here for the English version.

CRISPR/Cas9 kullanarak hedeflenen gen düzenleme büyük ölçüde anlayış genlerin biyolojik fonksiyonların kolaylaştırdı. Burada, biz oncogenic faaliyetlerini incelemek için model calreticulin mutasyonların sitokin bağımlı hematopoetik hücreler için CRISPR/Cas9 metodoloji kullanmaktadır.

Tags

Kanser araştırmaları sayı: 131 CRISPR Cas9 gen düzenleme sgRNA calreticulin sıralama muhabir
Read Article

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
Simple Hit Counter